Cognito Therapeutics Raises $73M Series B

Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. New investors Alzheimers Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and WS Investment Company (Wilson Sonsinis venture arm) joined the round. The Series B funding brings the total amount raised since inception to $93 million. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.